1.A clinical study on industrial hand injury(II).
Hyeung Gyo SEO ; Byeung Il LEE ; Seung Ha PARK ; Woo Kyung KIM ; Chun Eun CHUNG
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1991;18(1):153-160
No abstract available.
Hand*
2.DNA ploidy in gastric cancer.
Won Il CHO ; Jong Seo LEE ; Gyo Young LEE ; Seung Jin YOU ; Jae Hak LEE ; Sang Yong COO ; Kyo Young LEE
Journal of the Korean Surgical Society 1993;45(4):495-502
No abstract available.
DNA*
;
Ploidies*
;
Stomach Neoplasms*
3.A Case of Misidentification of Dermabacter hominis as Listeria grayi.
Young In KIM ; Kyoung Un PARK ; Il Joong PARK ; Seo Jin PARK ; Wee Gyo LEE
Korean Journal of Clinical Microbiology 2011;14(2):79-82
Listeria grayi is a catalase-positive, non-spore forming, and glucose-fermenting Gram-positive rod. L. grayi is widely distributed in environments such as soil, water and fresh food. Human infection by L. grayi is very rare, and there have been no cases reported in Korea, and only two cases worldwide. Dermabacter hominis is a relatively new species belonging to the coryneform bacteria and is a component of the normal human skin flora. D. hominis is a non-motile, glucose-fermenting, Gram-positive rod that has similar biochemical characteristics to L. grayi. The authors of the present study report a case initially misidentified as L. grayi via a traditional morphological and biochemical identification method but that was subsequently confirmed as D. hominis using sequence analysis of 16S rRNA.
Bacteria
;
Humans
;
Korea
;
Listeria
;
Sequence Analysis
;
Skin
;
Soil
4.A Case of Intraductal Papillary Mucinous Tumor Arising from the Accessory Pancreatic Duct.
Ho Hyung KANG ; Seong Je PARK ; Chang Gyo LEE ; Young Mi LEE ; Sun Jong KIM ; Bi Seok NHA ; Il Woo SUH ; Kyoung Ha PARK ; Hee Gon SONG ; Jae Myung KANG ; Yeon Ho JOO ; Dong Wan SEO ; Sung Koo LEE ; Myung Hwan KIM ; Young Il MIN ; Tae Kyoung KIM ; Eun Sil YU
Korean Journal of Gastrointestinal Endoscopy 2001;22(2):121-125
Mucin-producing tumors of the pancreas were first reported by Ohhashi and Takagi in 1980. Since then, many cases of intraductal papillary mucinous tumor (IPMT) of the pancreas, which is almost homonymous to mucin-producing tumors of the pancreas, have been reported. IPMTs are generally regarded as tumors with a favorable prognosis. Some IPMTs have invasiveness and this is always associated with a poor prognosis. Most IPMTs arise from the main pancreatic duct and IPMTs arising from the accessory pancreatic duct are relatively rare. Only 6 cases have been reported in the literature so far. Our patient was a 43-year old man who was admitted to the hospital due to recurrent pancreatitis. An endoscopic retrograde pancreatography revealed a patulous minor papilla orifice extruding mucin and a cystic lesion in a branch of the accessory duct. A pancreaticoduodenectomy was performed and a pathologic examination of the resected specimen showed intraductal papaillary mucinous neoplasm, low grade malignancy, in the accessory pancreatic duct and its branch. We herein report this interesting case with a review of the literature.
Adult
;
Humans
;
Mucins*
;
Pancreas
;
Pancreatic Ducts*
;
Pancreaticoduodenectomy
;
Pancreatitis
;
Prognosis
5.A case of MALT lymphoma of the thyroid accompanying Hashimoto's thyroiditis.
Tae Young LEE ; Eun Sang RYOO ; Il Song NAM ; Gi Young HONG ; Chan Hee HAN ; Suk Gi YOON ; Chul Hee KIM ; Dong Won BYUN ; Young Sun KIM ; Gyo Il SEO ; Myung Hi YOO ; So Young JIN
Korean Journal of Medicine 2001;61(3):281-285
Primary thyroid lymphomas constitute of up to 5% of all thyroid malignancies. Recently, mucosa-associated lymphoid tissue (MALT) lymphoma are relatively recognized as a B cell subset of non-Hodgkin's lymphoma. MALT-lymphomas are thought to develop from acquired lymphocytic tissue during the course of a chronic inflammatory or autoimmune process. In the thyroid , which is normally devoid of lymphocytic tissue, chronic autoimmune thyroiditis (Hashimoto's disease) has been associated with an increased risk of lymphoma, including MALT type. The clinical presentations include the enlarging of the neck mass, dysphagia, hoarsenes and choking or cold thyroid nodule. We report a case of MALToma of the thyroid accompanied by Hashimoto's thyroiditis with a review of the literature.
Airway Obstruction
;
Deglutition Disorders
;
Lymphoid Tissue
;
Lymphoma
;
Lymphoma, B-Cell, Marginal Zone*
;
Lymphoma, Non-Hodgkin
;
Neck
;
Thyroid Gland*
;
Thyroid Nodule
;
Thyroiditis*
;
Thyroiditis, Autoimmune
6.Validation of Electronic Foot Function Index in Patients with Foot and Ankle Disease: A Randomized, Prospective Multicenter Study
Dong Yeon LEE ; Yu Mi KIM ; Jun Hyung LEE ; Jin KIM ; Ji Beom KIM ; Bom Soo KIM ; Gi Won CHOI ; Sang Gyo SEO ; Jun Beom KIM ; Se Jin PARK ; Yoon Chung KIM ; Young Rak CHOI ; Dong Oh LEE ; Jae Ho CHO ; Dong Il CHUN ; Hyong Nyun KIM ; Jae Yong PARK
Journal of Korean Foot and Ankle Society 2019;23(1):24-30
PURPOSE: To evaluate the efficiency of the electronic foot function index (eFFI) through a prospective, random based, multi-institutional study. MATERIALS AND METHODS: The study included 227 patients ranging in age from 20 to 79 years, visited for surgery in different 15 institutes, and agreed to volunteer. The patients were assigned randomly into a paper-based evaluated group (n=113) and tablet-based evaluated group (n=114). The evaluation was done on the day of hospital admission and the method was changed on the second day of surgery and re-evaluated. PADAS 2.0 (https://www.proscore.kr) was used as an electronic evaluation program. RESULTS: There were no differences in age and sex in both groups. The intraclass correlation coefficient (ICC) evaluation revealed an eFFI ICC of 0.924, showing that both results were similar. The evaluation time was shorter in the tablet-based group than the paper-based group (paper vs tablet, 3.7±3.8 vs 2.3±1.3 minutes). Thirty-nine patients (17.2%) preferred to use paper and 131 patients (57.7%) preferred the tablet. Fifty-seven patients (25.1%) found both ways to be acceptable. CONCLUSION: eFFI through tablet devices appears to be more constant than the paper-based program. In addition, it required a shorter amount of time and the patients tended to prefer the tablet-based program. Overall, tablet and cloud system can be beneficial to a clinical study.
Academies and Institutes
;
Ankle
;
Clinical Study
;
Foot
;
Humans
;
Methods
;
Prospective Studies
;
Volunteers
7.Quality of Anticoagulation and Treatment Satisfaction in Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonist: Result from the KORean Atrial Fibrillation Investigation II.
Seil OH ; June Soo KIM ; Yong Seog OH ; Dong Gu SHIN ; Hui Nam PAK ; Gyo Seung HWANG ; Kee Joon CHOI ; Jin Bae KIM ; Man Young LEE ; Hyung Wook PARK ; Dae Kyeong KIM ; Eun Sun JIN ; Jaeseok PARK ; Il Young OH ; Dae Hee SHIN ; Hyoung Seob PARK ; Jun Hyung KIM ; Nam Ho KIM ; Min Soo AHN ; Bo Jeong SEO ; Young Joo KIM ; Seongsik KANG ; Juneyoung LEE ; Young Hoon KIM
Journal of Korean Medical Science 2018;33(49):e323-
BACKGROUND: Vitamin K antagonist (VKA) to prevent thromboembolism in non-valvular atrial fibrillation (NVAF) patients has limitations such as drug interaction. This study investigated the clinical characteristics of Korean patients treated with VKA for stroke prevention and assessed quality of VKA therapy and treatment satisfaction. METHODS: We conducted a multicenter, prospective, non-interventional study. Patients with CHADS2 ≥ 1 and treated with VKA (started within the last 3 months) were enrolled from April 2013 to March 2014. Demographic and clinical features including risk factors of stroke and VKA treatment information was collected at baseline. Treatment patterns and international normalized ratio (INR) level were evaluated during follow-up. Time in therapeutic range (TTR) > 60% indicated well-controlled INR. Treatment satisfaction on the VKA use was measured by Treatment Satisfaction Questionnaire for Medication (TSQM) after 3 months of follow-up. RESULTS: A total of 877 patients (age, 67; male, 60%) were enrolled and followed up for one year. More than half of patients (56%) had CHADS2 ≥ 2 and 83.6% had CHA2DS2-VASc ≥ 2. A total of 852 patients had one or more INR measurement during their follow-up period. Among those patients, 25.5% discontinued VKA treatment during follow-up. Of all patients, 626 patients (73%) had poor-controlled INR (TTR < 60%) measure. Patients' treatment satisfaction measured with TSQM was 55.6 in global satisfaction domain. CONCLUSION: INR was poorly controlled in Korean NVAF patients treated with VKA. VKA users also showed low treatment satisfaction.
Atrial Fibrillation*
;
Drug Interactions
;
Follow-Up Studies
;
Humans
;
International Normalized Ratio
;
Male
;
Prospective Studies
;
Risk Factors
;
Stroke
;
Thromboembolism
;
Vitamin K*
;
Vitamins*